K06A9.1

Caenorhabditis elegans

Predicted to be located in membrane.

ddo-2

Caenorhabditis elegans

Enables D-aspartate oxidase activity and D-glutamate oxidase activity. Involved in aspartate catabolic process. Predicted to be located in peroxisomal matrix. Expressed in body wall musculature; intestinal cell; and pharyngeal muscle cell.

rpac-19

Caenorhabditis elegans

Predicted to enable protein dimerization activity. Predicted to contribute to RNA polymerase I activity and RNA polymerase III activity. Predicted to be involved in transcription by RNA polymerase III and transcription elongation by RNA polymerase I. Predicted to be located in nucleus. Predicted to be part of RNA polymerase I complex and RNA polymerase III complex. Used to study obesity. Human ortholog(s) of this gene implicated in Treacher Collins syndrome 2. Is an ortholog of human POLR1D (RNA polymerase I and III subunit D).

daao-1

Caenorhabditis elegans

Enables D-amino-acid oxidase activity. Predicted to be involved in D-amino acid catabolic process and digestion. Predicted to be located in cytoplasm. Expressed in intestinal cell. Human ortholog(s) of this gene implicated in schizophrenia. Is an ortholog of human DDO (D-aspartate oxidase).

ddo-1

Caenorhabditis elegans

Enables D-aspartate oxidase activity; D-glutamate oxidase activity; and FAD binding activity. Predicted to be involved in D-amino acid catabolic process. Predicted to be located in peroxisomal matrix. Expressed in hypodermis and intestinal cell. Human ortholog(s) of this gene implicated in schizophrenia. Is an ortholog of human DAO (D-amino acid oxidase).

F32D8.12

Caenorhabditis elegans

Predicted to enable D-lactate dehydrogenase (cytochrome) activity; D-lactate dehydrogenase activity; and flavin adenine dinucleotide binding activity. Predicted to be involved in lactate catabolic process. Predicted to be located in mitochondrion. Is an ortholog of human LDHD (lactate dehydrogenase D).

F09G2.8

Caenorhabditis elegans

Predicted to enable phospholipase D activity. Predicted to be involved in lipid catabolic process. Predicted to be located in membrane. Expressed in tail. Human ortholog(s) of this gene implicated in spinocerebellar ataxia 46. Is an ortholog of human PLD3 (phospholipase D family member 3) and PLD4 (phospholipase D family member 4).

R119.5

Caenorhabditis elegans

Predicted to enable protein-L-isoaspartate (D-aspartate) O-methyltransferase activity. Predicted to be involved in protein modification process. Predicted to be located in cytoplasm. Is an ortholog of human PCMTD1 (protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1) and PCMTD2 (protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2).

rpoa-2

Caenorhabditis elegans

Predicted to enable DNA binding activity; DNA-directed 5'-3' RNA polymerase activity; and ribonucleoside binding activity. Predicted to contribute to RNA polymerase I activity. Predicted to be involved in transcription by RNA polymerase I. Located in nucleolus. Expressed in several structures, including intestine. Human ortholog(s) of this gene implicated in Treacher Collins syndrome 4. Is an ortholog of human POLR1B (RNA polymerase I subunit B).

mcp-1

Caenorhabditis elegans

Enables GDP-D-glucose phosphorylase activity. Involved in glucose metabolic process. Located in cytoplasm. Expressed in anterior hypodermis; nervous system; reproductive system; and spermatheca. Is an ortholog of human GDPGP1 (GDP-D-glucose phosphorylase 1).